Trials / Completed
CompletedNCT02747511
IV Haloperidol for the Treatment of Headache in the ED
Intravenous Haloperidol for the Treatment of Headache in the Emergency Department
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Western Michigan University School of Medicine · Academic / Other
- Sex
- All
- Age
- 13 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Single center, double-blind, randomized, placebo-controlled trial evaluating analog pain scores in patients who present to the emergency department (ED) with a complaint of headache. A total of 150 patients age 13-55 presenting to the emergency department with headache will be enrolled from October 2015 - October 2016. Patients will be randomized and pain scores and side effects will be recorded at 0, 30, 60, and 90 minutes. Follow-up will be performed by telephone at 24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Haloperidol | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2016-04-21
- Last updated
- 2017-12-12
Source: ClinicalTrials.gov record NCT02747511. Inclusion in this directory is not an endorsement.